Compounds That Target LCK

LCK proto-oncogene, Src family tyrosine kinase · 109 compounds in BiohacksAI corpus

LCK (LCK proto-oncogene, Src family tyrosine kinase) is a biological target with 109 documented compound interactions in the BiohacksAI corpus. The compounds listed below have been identified through computational analysis of BindingDB binding assay data and PubMed literature. Each interaction is ranked by confidence score reflecting the breadth and strength of experimental evidence. This resource supports research into LCK modulation for therapeutic and biohacking applications.

View LCK target page →UniProt: P06239 ↗

All 50 Compounds — Ranked by Evidence

Tamoxifen

5.88

confidence

Gefitinib

5.67

confidence

Erlotinib

5.55

confidence

Imatinib

5.47

confidence

Elliptecine

5.21

confidence

Sb 203580

4.92

confidence

Ibrutinib

4.86

confidence

Tofacitinib

4.65

confidence

Alvocidib

4.52

confidence

Nelfinavir

4.51

confidence

Cabozantinib

4.39

confidence

Foretinib

4.34

confidence

Tozasertib

4.33

confidence

Vandetanib

4.30

confidence

Ponatinib

4.26

confidence

Caffeic Acid Phenethyl Ester

4.25

confidence

Ceritinib

4.19

confidence

Nilotinib

4.17

confidence

Bosutinib

4.08

confidence

Doramapimod

4.06

confidence

Quizartinib

3.99

confidence

Midostaurin

3.85

confidence

Brigatinib

3.81

confidence

Pazopanib

3.69

confidence

Neratinib

3.66

confidence

Nintedanib

3.61

confidence

Canertinib

3.53

confidence

Pelitinib

3.50

confidence

Tae 684

3.43

confidence

Pexidartinib

3.43

confidence

Fedratinib

3.40

confidence

Dobutamine

3.37

confidence

Bms 777607

3.37

confidence

Mln 8054

3.33

confidence

Saracatinib

3.33

confidence

Dabrafenib

3.30

confidence

Neflamapimod

3.30

confidence

Alisertib

3.30

confidence

Tandutinib

3.22

confidence

Dorsomorphin

3.14

confidence

Dacomitinib Anhydrous

3.14

confidence

Dovitinib

3.09

confidence

At 9283

3.09

confidence

Dasatinib Anhydrous

3.09

confidence

Upadacitinib

3.09

confidence

Lestaurtinib

3.04

confidence

Pacritinib

3.04

confidence

Ruboxistaurin

2.94

confidence

Danusertib

2.94

confidence

Defosbarasertib

2.89

confidence

The compounds above were identified through computational analysis of BindingDB binding assay data and PubMed literature for LCK (LCK proto-oncogene, Src family tyrosine kinase). Confidence scores reflect the strength and breadth of experimental evidence.

Explore related resources: LCK target overview · All biological targets · Biological pathways

Data from BindingDB and PubMed. For research purposes only. Not medical advice.